In light of the recent outbreak of COVID in India, PharmAust contacted Syngene this week and they confirmed that their timeline to manufacture GMP grade MPL currently remains unchanged.
Ann: Appendix 4C and Quarterly Update, page-3
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $89.24K | 403.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 142257 | 3 |
View Market Depth
| Last trade - 15.52pm 17/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |